focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-On the radar: Total, Swiss Re, Spanish banks

Fri, 30th Oct 2020 07:48

Welcome to the home for real-time coverage of markets brought to
you by Reuters reporters. You can share your thoughts with us at
markets.research@thomsonreuters.com

ON THE RADAR: TOTAL, SWISS RE, SPANISH BANKS (0738 GMT)

European stocks are set to open sharply lower as worries
about possible new lockdowns coupled with risks of a contested
outcome of U.S. elections rattle investors.

A batch of positive results is not giving much support.

Swiss Re stocks are up 0.5% in premarket trade as
the reinsurance company reported a smaller-than-expected net
loss in the first nine months after booking claims and reserves
of $3 billion related to COVID-19.

Total trimmed its investment target for 2020,
though the group returned to profit in the third quarter and
maintained its dividend.

The pandemic hit results of Spanish banks, which however
came out better than expected.

Banco Sabadell's third-quarter net profit fell 77%
from a year ago due to higher provisions but beat forecast,
while the lender announced an efficiency plan.

Caixabank posted a net profit of 522 million euros
versus analysts’ expectations of 319 million euros.

BBVA net profit beat market expectations, but was
down 6.9% from the same period a year ago to 1.14 billion euros
on more loan loss provisions.

Air France-KLM unveiled a 1.05 billion-euro better
than expected operating loss and warned of worse to come as a
resurgent coronavirus brings new travel curbs.

Shares in LafargeHolcim are up 0.7% after the
company raised its guidance, after results.

Proximus reported Ebitda above analysts
expectations and raised its full year guidance.

Amundi reported a high level of net inflows and
an operating income of 307 million euros.

BP plans to stop producing fuel in Australia and will
convert its loss-making Kwinana oil refinery, the biggest of the
country's four.

Julius Baer Gruppe plans to set up business in
China in partnership with a local financial firm.

Lonza Group agreed with AstraZeneca to make
AZD7442 an experimental combination of two antibodies that may
be used to prevent and treat COVID-19.

(Stefano Rebaudo)

*****

EUROPE'S STOCK FUTURES WELL IN THE RED (0628 GMT)

European stock futures are sharply lower as record numbers
of coronavirus cases across the world and the outcome of U.S.
elections remain the major concern for investors.

The ECB signalling it will provide more stimulus to fight
the impact of the pandemic gave some support to stocks yesterday
but wasn’t far from analysts’ expectations.

U.S. stock futures are down around 2%, after a positive
session on Wall Street, helped by quarterly reports from tech
giants and solid GDP data.

(Stefano Rebaudo)

*****

More News
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.